Clinical Trial Update: Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessed whether phenethyl isothiocyanate can prevent lung cancer in smokers; the trial is completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Tobacco Use Disorder

Drugs mentioned

• Phenethyl Isothiocyanate (phenethyl isothiocyanate)

Snippet

Sponsor: University of Minnesota | Conditions: Lung Cancer, Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04